← Back to Search

Asthma CHAMPS Program for Childhood Asthma

N/A
Recruiting
Led By Michelle N Ealin, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children with asthma diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to help children in Baltimore City elementary schools manage their asthma better. The program teaches kids and their caregivers how to control asthma symptoms, reducing school absences and emergency healthcare visits.

Who is the study for?
This trial is for adults who care for children with asthma or staff at Baltimore City K-8 Public Schools. It includes kids diagnosed with asthma and enrolled in schools participating in Asthma CHAMPS. Those unwilling to consent, or children unwilling to provide assent are excluded.
What is being tested?
The study tests the Asthma CHAMPS program's effectiveness in reducing asthma disparities among children by implementing it across 32 elementary schools. The design involves a stepped wedge trial to assess its impact on school attendance, healthcare use, and overall asthma control.
What are the potential side effects?
Since this trial focuses on an educational and management program rather than medication, traditional side effects are not applicable. However, there may be indirect impacts related to changes in daily routines or stress levels due to new management practices.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child has been diagnosed with asthma.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Asthma-related absences
Emergency Department (ED) utilization for asthma by children
Hospitalization for asthma by children
+1 more
Secondary study objectives
Acceptability of Intervention (AIM) as assessed by a 4 item questionnaire
Feasibility of Intervention (FIM) as assessed by a 4 item questionnaire
Intervention Appropriateness Measure (IAM) as assessed by a 4 item questionnaire
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: School staffExperimental Treatment2 Interventions
School staff in a K-8 school participating in Asthma CHAMPS
Group II: Children with asthmaExperimental Treatment2 Interventions
Aged 5-13 and enrolled in Baltimore City Public School participating in Asthma CHAMPS
Group III: Caregivers of children with asthmaExperimental Treatment2 Interventions
Caregiver of a child with asthma that is aged 5-13 enrolled in a Baltimore City Public School participating in Asthma CHAMPS

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for childhood asthma include inhaled corticosteroids (ICS), which reduce inflammation in the airways, and short-acting beta agonists (SABAs), which provide quick relief by relaxing bronchial muscles. Long-acting beta agonists (LABAs) are often used in combination with ICS for long-term control. The Asthma CHAMPS program emphasizes a multi-faceted approach, combining medical treatment with education, environmental control, and healthcare coordination. This comprehensive strategy is vital for childhood asthma patients as it not only addresses the immediate symptoms but also reduces exposure to triggers and ensures consistent management, leading to better overall asthma control and fewer exacerbations.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,316 Previous Clinical Trials
14,871,781 Total Patients Enrolled
Baltimore City Public SchoolsUNKNOWN
Baltimore City Health DepartmentOTHER
8 Previous Clinical Trials
18,175 Total Patients Enrolled

Media Library

Asthma CHAMPS Clinical Trial Eligibility Overview. Trial Name: NCT05814510 — N/A
Childhood Asthma Research Study Groups: School staff, Children with asthma, Caregivers of children with asthma
Childhood Asthma Clinical Trial 2023: Asthma CHAMPS Highlights & Side Effects. Trial Name: NCT05814510 — N/A
Asthma CHAMPS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05814510 — N/A
~667 spots leftby Jun 2027